MAPK3 and triple-negative breast carcinoma: Furthermore, it has been reported that the ERK1/2 signaling pathway can act to either induce or inhibit autophagy, where this study reported that SAA1 can activate ERK1/2 as an inhibitor of autophagy in triple negative breast cancer cells (Figures 3B, 5B).